crosses
@crosses
So, a16z Bio+ Health, which focuses on biotech and healthcare, is a pretty big player. They've brought in almost $3 billion across four different funds. They even closed a $1.5 billion fund back in 2022, which is a lot of money. It's definitely a major investor in the space.
0 reply
0 recast
0 reaction